MedTrace Logo

Comparison Between Free Thyroxine and Thyroid Stimulating Hormone Levels on Melasma Severity

NCT04359719 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2020-04-29

No results posted yet for this study

Summary

The objective of the study was to compare the level of serum FT4 and TSH in patients with mild melasma and moderate-severe melasma. The determination of melasma lesion could also be known by using Janus II facial analysis UV light and polarization light to analyze the pattern of hyperpigmentation on melasma. This was a descriptive-analytic study used a cross-sectional method that was performed in 2019 at two different dermatology and venerology clinics in Indonesia, Cipto Mangunkusumo Hospital Jakarta and Gatot Subroto Army Hospital Jakarta. Forty-eight subjects with melasma, 50% diagnosed with mild melasma and 50% with moderate-severe melasma according to the modified melasma area and severity index (mMASI) score. The level of serum FT4 and TSH were then measured in both groups of the patients.

Conditions

  • Melasma

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Irma B Sitohang, MD, PhD · Fakultas Kedokteran Universitas Indonesia

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-15
Primary Completion
2019-07-26
Completion
2019-10-26

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04359719 on ClinicalTrials.gov